5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid has been researched along with Asthma in 1 studies
5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid: RN given refers to (S-(R*,R*-(E,E,Z,Z)))-isomer
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruijnzeel, P | 1 |
| Storz, E | 1 |
| van der Donk, E | 1 |
| Bruijnzeel-Koomen, C | 1 |
1 other study available for 5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid and Asthma
| Article | Year |
|---|---|
Skin eosinophilia in patients with allergic asthma, patients with nonallergic asthma, and healthy controls. II: 20-Hydroxy-leukotriene B4 is a potent in vivo and in vitro eosinophil chemotactic factor in nonallergic asthma.
Topics: Adult; Asthma; Chemotaxis, Leukocyte; Eosinophils; Female; Humans; Hypersensitivity; Leukotriene B4; | 1993 |